ABK’s O’Connor Is a Medtech Star
In the midst of interviewing ABK Biomedical's new CEO Pat O’Connor on the Halifax company’s direction, I realized that the story I should write was about O’Connor himself.
Last October, the company announced it had raised $1.25 million in funding from the Atlantic Canada Opportunities Agency, Innovacorp and a variety of sources, and co-founder and chief scientific officer Daniel Boyd said,